The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
Abstract
OBJECTIVE: The authors' goal was to study the relationship between smoking status and clinical characteristics in schizophrenic patients. METHOD: Seventy-eight schizophrenic outpatients were assessed by a single rater using the Brief Psychiatric Rating Scale (BPRS), the Abnormal Involuntary Movement Scale, and the Simpson-Angus Scale for extrapyramidal symptoms. Current smokers (N = 58) were compared with nonsmokers (N = 20) on clinical variables by independent t tests and chi-square tests. Differences in outcome variables were tested by multiple analysis of covariance (ANCOVA) with smoking status and gender as factors and age, neuroleptic dose, and caffeine consumption as covariates. RESULTS: Seventy-four percent of patients were current smokers and reported a mean of 19 cigarettes smoked per day. Compared to nonsmokers, current smokers were significantly more likely to be men, to be younger, and to have had an earlier age at onset and a greater number of previous hospitalizations. Current smokers and nonsmokers received mean neuroleptic doses of 1160 and 542 mg/day (chlorpromazine equivalents); the difference was significant. Current smokers also displayed significantly less parkinsonism and more akathisia and had higher total scores on the BPRS. Overall multiple ANCOVA demonstrated a significant main effect for smoking status but not gender or the interaction between gender and smoking status. Univariate ANCOVAs demonstrated a significant main effect of smoking status only for the Simpson-Angus Scale score. CONCLUSIONS: Cigarette smokers receive significantly higher neuroleptic doses, in part because of a smoking-induced increase in neuroleptic metabolism. Smoking is also associated with significant reduction in levels of parkinsonism. Smoking status is a significant factor that should be considered in assessment of neuroleptic dose requirements and neuroleptic side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Clarke, P. B. S., & Pert, A. (1985) · Brain Research · doi:10.1016/0006-8993(85)90456-1 · Cited by 527
Tobacco, alcohol, and caffeine use: A review of their interrelationships.
Istvan, J., & Matarazzo, J. D. (1984) · Psychological Bulletin · doi:10.1037//0033-2909.95.2.301 · Cited by 487
Neuropsychological Assessment of Monozygotic Twins Discordant for Schizophrenia
Goldberg, T. E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230082013 · Cited by 384
Pomerlau (1984) · doi:10.1016/0149-7634(84)90007-1 · Cited by 378
A Scale to Differentiate between Types of Smoking as Related to the Management of Affect
Ikard, F. F., Green, D. E., & Horn, D. (1969) · International Journal of the Addictions · doi:10.3109/10826086909062040 · Cited by 357
A Review of Psychoactive Substance Use and Abuse in Schizophrenia: Patterns of Drug Choice
SCHNEIER, F. R., & SIRIS, S. G. (1987) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198711000-00001 · Cited by 319
Cigarette smoking and Parkinson's disease
Baron, J. A. (1986) · Neurology · doi:10.1212/wnl.36.11.1490 · Cited by 291
Giorguieff-Chesselet, M. F., Kemel, M. L., Wandscheer, D., & Glowinski, J. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90469-7 · Cited by 249
Smoking, nicotine and human performance
WESNES, K., & WARBURTON, D. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90072-4 · Cited by 243
Smoking and Parkinson's disease.
Godwin-Austen, R. B., Lee, P. N., Marmot, M. G., & Stern, G. M. (1982) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.7.577 · Cited by 175
Smoking and Malignancy in Schizophrenia
Masterson, E. L., & O’Shea, B. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.145.4.429 · Cited by 151
Cigarette smoking and Parkinson disease
Baumann, R. J., Jameson, H. D., McKean, H. E., Haack, D. G., & Weisberg, L. M. (1980) · Neurology · doi:10.1212/wnl.30.8.839 · Cited by 135
EPIDEMIOLOGIC STUDIES OF PARKINSON'S DISEASE
Kessler, I. I., & Diamond, E. L. (1971) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121289 · Cited by 130
Effects of the acute administration of caffeine in patients with schizophrenia
Lucas, P. B., Pickar, D., Kelsoe, J., Rapaport, M., Pato, C., & Hommer, D. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90429-6 · Cited by 125
Jann, M. W., Saklad, S. R., Ereshefsky, L., Richards, A. L., Harrington, C. A., & Davis, C. M. (1986) · Psychopharmacology · doi:10.1007/bf00174062 · Cited by 123
Nicotine exposure and tardive dyskinesia
YASSA, R., Lal, S., Korpassy, A., & Ally, J. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90131-4 · Cited by 119
Effects of smoking on fluphenazine clearance in psychiatric inpatients
Ereshefsky, L., Jann, M. W., Saklad, S. R., Davis, C. M., Richards, A. L., & BURCH, N. R. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90063-0 · Cited by 118
Cigarette smoking and neuroleptic-induced parkinsonism
Decina, P., Caracci, G., Sandik, R., Berman, W., Mukherjee, S., & Scapicchio, P. L. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90483-i · Cited by 108
Facilitation of learning and state dependency with nicotine
Warburton, D. M., Wesnes, K. A., Shergold, K., & James, M. (1986) · Psychopharmacology · doi:10.1007/bf00175189 · Cited by 99
Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome
Sanberg, P. R., Mcconville, B. J., Fogelson, H. M., Manderscheid, P. Z., Parker, K. W., Blythe, M. M., Klykylo, W. M., & Norman, A. B. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90186-8 · Cited by 90
Effect of adrenaline, noradrenaline, atropine, and nicotine on some types of human tremor.
Marshall, J., & Schnieden, H. (1966) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.29.3.214 · Cited by 81
Andersson, K., Fuxé, K., & Agnati, L. F. (1981) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1981.tb06827.x · Cited by 78
Fuxé, K., Jansson, A. M., Jansson, A., Andersson, K., Eneroth, P. H. E., & Agnati, L. F. (1990) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169727 · Cited by 70
Nicotine and the tobacco smoking habit
Balfour, D. J. K. (1984) · Medical Entomology and Zoology · Cited by 61
The Treatment of Post-Encephalitig Parkinsonism by Nicotine
Moll, H. H. (1926) · BMJ · doi:10.1136/bmj.1.3416.1079 · Cited by 60
Swett, C. P. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760140063010 · Cited by 57
Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia
Newcomer, J. W., Faustman, W. O., Yeh, W., & Csernansky, J. G. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90093-k · Cited by 55
Smoking and tardive dyskinesia
Binder, R. L., Kazamatsuri, H., Nishimura, T., & McNiel, D. E. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90038-2 · Cited by 51
Effects of Caffeine on Behavior of Schizophrenic Inpatients
Koczapski, A. B., Paredes, J., Kogan, C., Ledwidge, B., & Higenbottam, J. A. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.2.339 · Cited by 48
Cigarette smoking and chlorpromazine disposition and actions
Pantuck, E. J., Pantuck, C. B., Anderson, K. E., Conney, A. H., & Kappas, A. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.72 · Cited by 46
May, P. R. A., Lee, M. A., & Bacon, R. C. (1983) · Clinical Neuropharmacology · doi:10.1097/00002826-198300061-00006 · Cited by 45
Smoking in Chronic Schizophrenia
Gopalaswamy, A. K., & Morgan, R. (1986) · The British Journal of Psychiatry · doi:10.1192/s0007125000139856 · Cited by 42
Henningfield, J. E., & Woodson, P. P. (1989) · Journal of Substance Abuse · doi:10.1016/s0899-3289(18)30006-3 · Cited by 32
Janson, A. M., Agnati, L. F., Fuxé, K., Cintra, A., Sundström, E., Zini, I., Toffano, G., & Goldstein, M. (1988) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1988.tb08371.x · Cited by 29
Schedule-induction of nicotine self-administration
Slifer, B. L. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90407-0 · Cited by 27
Nicotine: An addictive substance or a therapeutic agent?
Warburton, D. M. (1989) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9146-2_1 · Cited by 21
Response to "Effects of Caffeine on Behavior of Schizophrenic Inpatients"
Hyde, A. P. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.371 · Cited by 20
Cited by
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1992-09-01
- Volume
- 149
- Issue
- 9
- Pages
- 1189-1194
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1777700014
- Cited by
- 579
- References
- 42
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.